BURGESS DANIEL D

CIK 00012396507 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001239650

Recent Transactions

50 trades

Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Common Stock
2026-01-07$221.50/sh−150→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−11,100→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−20,500→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−2,125→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−2,125→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−1,400→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−875→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−875→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−550→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−550→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−550→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−450→ 0 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2025-06-18+11,100→ 11,100 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-12-17+20,500→ 20,500 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2024-05-23+67,000→ 67,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2023-06-22+42,500→ 42,500 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2023-05-24+55,000→ 55,000 total
Sale
Nabriva Therapeutics plc
Ordinary Shares
2022-08-02$0.19/sh−11,341→ 10,384 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2022-06-22+28,000→ 28,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2022-05-25+41,000→ 41,000 total
Sale
Nabriva Therapeutics plc
Ordinary Shares
2021-08-02$1.20/sh−1,125→ 21,725 total
Award
Nabriva Therapeutics plc
Share Options
2021-07-28+35,000→ 35,000 total
Award
Nabriva Therapeutics plc
Ordinary Shares
2021-07-28+17,500→ 22,850 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2021-06-23+17,500→ 17,500 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2021-06-03+22,000→ 22,000 total
Award
Nabriva Therapeutics plc
Ordinary Shares
2020-07-29+17,500→ 53,500 total
Award
Nabriva Therapeutics plc
Stock Options
2020-07-29+35,000→ 35,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2020-06-25+17,500→ 17,500 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2020-05-28+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2019-08-17+22,000→ 22,000 total
Award
Nabriva Therapeutics plc
Stock Option
2019-07-31+35,000→ 35,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2019-06-17+11,000→ 11,000 total
Award
Nabriva Therapeutics plc
Stock Option
2018-08-01+15,000→ 15,000 total
Purchase
Nabriva Therapeutics plc
Ordinary Shares
2018-07-31$2.75/sh+36,000→ 36,000 total
Award
Arbutus Biopharma Corp$ABUS
Director Stock Option (Right to Buy)
2018-06-19+22,000→ 22,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2018-06-13+11,000→ 11,000 total
Award
Nabriva Therapeutics plc
Stock Option
2018-05-02+29,000→ 29,000 total
Award
Nabriva Therapeutics plc
Stock Option
2017-09-15+10,100→ 10,100 total
Other
Nabriva Therapeutics Legacy plc
Stock Option
2017-06-23+20,200→ 20,200 total
Other
Nabriva Therapeutics Legacy plc
Stock Option
2017-06-23+10,100→ 10,100 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2017-06-22+11,000→ 11,000 total
Award
Arbutus Biopharma Corp$ABUS
Director Stock Option Grant (Right to Buy)
2017-06-21+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Director Stock Option (Right to Buy)
2017-03-24+50,000→ 50,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2016-06-22+9,000→ 9,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2015-06-09+9,000→ 9,000 total
Purchase
Cidara Therapeutics, Inc.$CDTX
Common Stock
2015-04-20$16.00/sh+3,000→ 3,000 total
Disposition to Issuer
SANTARUS INC
Stock Options (right to buy)
2014-01-02$28.67/sh−32,000→ 0 total
Disposition to Issuer
SANTARUS INC
Stock Options (right to buy)
2014-01-02$22.00/sh−40,000→ 0 total
Disposition to Issuer
SANTARUS INC
Stock Options (right to buy)
2014-01-02$30.82/sh−12,000→ 0 total

Companies

Recent Filings

Address

C/O CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE SUITE 101

SAN DIEGO, CA, 92121

View on SEC.gov